Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T11:41:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    An NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-24T11:37:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T12:55:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T13:13:17.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new page revision label (v3.7.0) is added to the record history, replacing the previous v3.6.6 label. This reflects a minor update to the revision metadata of the study page.
    Difference
    0.1%
    Check dated 2026-09-19T18:21:58.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The record history now includes a new Revision: v3.6.6 entry, and the previous Revision: v3.6.5 entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-08-29T18:18:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.